Prospective Evaluation of Operating Characteristics of Prostate Cancer Detection Biomarkers-Reference-Cited by-同舟云学术

Prospective Evaluation of Operating Characteristics of Prostate Cancer Detection Biomarkers

Published:2011-01 Issue:1 Volume:185 Page:104-110
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Liang Yuanyuan¹²³,Ankerst Donna P.¹²⁴,Ketchum Norma S.²,Ercole Barbara¹,Shah Girish⁵,Shaughnessy John D.⁶,Leach Robin J.¹⁷⁸,Thompson Ian M.¹

Affiliation:

1. Department of Urology, University of Texas Health Science Center, San Antonio, Texas

2. Department of Epidemiology and Biostatistics, University of Texas Health Science Center, San Antonio, Texas

3. University of Texas Houston School of Public Health, Houston, Texas

4. Department of Mathematics, Technische Universitaet Muenchen, Muenchen, Germany

5. Department of Basic Pharmaceutical Sciences, Monroe, Louisiana

6. Donna D. and Donald M. Lambert Laboratory of Myeloma Genetics, University of Arkansas for Medical Sciences, Little Rock, Arkansas

7. Department of Pediatrics, University of Texas Health Science Center, San Antonio, Texas

8. Department of Cellular and Structural Biology, University of Texas Health Science Center, San Antonio, Texas

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference30 articles.

1. American Cancer Society guideline for the early detection of prostate cancer: update 2010;Wolf;CA Cancer J Clin,2010

2. The role of the Wnt-signaling antagonist DKK1 in the development of osteolytic lesions in multiple myeloma;Tian;N Engl J Med,2003

3. Shah GV, Srivastava AK and Iczkowski K: Neuroendocrine marker: a novel, reliable early stage marker for prostate cancer. Presented at the 100th annual meeting of the American Association for Cancer Research, Denver, Colorado, April 18–22, 2009, abstract 4826.

4. The operating characteristics of prostate-specific antigen in a population with initial PSA of 3.0 ng/ml or lower;Thompson;JAMA,2005

5. On the sample size for studies based upon McNemar's test;Lachenbruch;Stat Med,1992

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The altered levels of adiponectin - leptin as predictive biomarkers to estimate the severity of prostate cancer;Biomedicine;2022-11-14

2. Prostate health index (PHI) as a reliable biomarker for prostate cancer: a systematic review and meta-analysis;Clinical Chemistry and Laboratory Medicine (CCLM);2022-05-16

3. UPDATE – 2022 Canadian Urological Association recommendations on prostate cancer screening and early diagnosis: Endorsement of the 2021 Cancer Care Ontario guidelines on prostate multiparametric magnetic resonance imaging;Canadian Urological Association Journal;2022-03-31

4. The prostate health index and the percentage of [-2]proPSA maintain their diagnostic performance when calculated with total and free PSA from different manufacturers;Clinical Chemistry and Laboratory Medicine (CCLM);2021-07-27

5. Prostate Cancer Biomarker Development: National Cancer Institute's Early Detection Research Network Prostate Cancer Collaborative Group Review;Cancer Epidemiology Biomarkers & Prevention;2020-10-22